Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 1
1987 3
1988 2
1989 1
1990 2
1992 2
1993 1
1995 2
1996 2
1997 5
1998 4
1999 2
2000 2
2001 2
2002 5
2003 6
2004 6
2005 6
2006 7
2007 5
2008 10
2009 5
2010 5
2011 6
2012 4
2013 4
2014 4
2015 4
2016 3
2017 5
2018 1
2019 6
2020 5
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R; LAPLACE-2 Investigators. Robinson JG, et al. JAMA. 2014 May 14;311(18):1870-82. doi: 10.1001/jama.2014.4030. JAMA. 2014. PMID: 24825642 Clinical Trial.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Diabetes Mellitus and Bone Metabolism.
Kasperk C, Georgescu C, Nawroth P. Kasperk C, et al. Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):213-217. doi: 10.1055/s-0042-123036. Epub 2017 Jan 10. Exp Clin Endocrinol Diabetes. 2017. PMID: 28073133 Review.
[Screening for osteoporosis].
Kasperk C. Kasperk C. Radiologe. 2008 Jan;48(1):63-70. doi: 10.1007/s00117-007-1557-x. Radiologe. 2008. PMID: 17972058 Review. German.
[Therapeutic management of acromegaly].
Metzner C, Hadziselimovic S, Grafe I, Nawroth P, Kasperk C. Metzner C, et al. Among authors: kasperk c. Med Klin (Munich). 2006 Jan 15;101(1):15-23. doi: 10.1007/s00063-006-1004-1. Med Klin (Munich). 2006. PMID: 16418810 Review. German.
[AGE-RAGE: a hypothesis or a mechanism?].
Isermann B, Bierhaus A, Humpert PM, Rudofsky G, Chavakis T, Ritzel R, Wendt T, Morcos M, Kasperk C, Hamann A, Nawroth PP. Isermann B, et al. Among authors: kasperk c. Herz. 2004 Aug;29(5):504-9. doi: 10.1007/s00059-004-2611-3. Herz. 2004. PMID: 15340736 Review. German.
119 results